Tafamadis Cluster F

Discussion in 'Pfizer' started by anonymous, May 13, 2019 at 6:29 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    What percentage of the patients the company claims exist are going to get this drug? How much will catalog price be vs actual after discounts? They really want the cluster 2 sales force to promote this along with a rare disease single drug sales force?how much money does Pfizer have to burn?
    So may little fiefdoms surviving a reorg! They are making a big bet on the pipeline here. If I was planning to be here 5 or more years I would be working hard to get into Oncology. We are done as a CV powerhouse.
     

  2. anonymous

    anonymous Guest

    All bets on the Pfizer pipeline during the last 10 years have gone directly into the crapper. Structuring any field force around rare disease/orphan products only leads to a handful of viable jobs around the hyperspecialists who service those patients.
     
  3. anonymous

    anonymous Guest

    It's called rare disease for a reason. There aren't many patients, and not many Drs who treat.
     
  4. anonymous

    anonymous Guest

    And not many reps are needed even for a blockbuster
     
  5. anonymous

    anonymous Guest

    True. Yet there are now 3 divisions with it. Overkill as usual!
     
  6. anonymous

    anonymous Guest

    CV “powerhouse” ????? When? Where? with what? Pfizer was never a powerhouse in anything but buying companies and their powerhouse products.
     
  7. anonymous

    anonymous Guest

    A long time ago, Pfizer was a CV powerhouse with drugs like Procardia, Procardia XL and Norvasc.
     
  8. anonymous

    anonymous Guest

    Remember that only reason you were moved to this role is because no one in their right mind would come here especially for Rare Disease
    This organization is perfect for those who don’t really have to influence and push that hard in the field.
    Essentially a “me too” organization with products that will sell themselves sooner or later.
    When you drop the line of “for your next 10 patients in this space, keep in mind that’s for the next 3 yrs!

    So, all the positive diagnoses with scans and biopsies are not real. You are correct, and the annals of medicine are wrong. This disease is not real. We are wasting our time. Good to know. Now go log in some fake calls on doctors you have never met, and enjoy working in your "pod" with the other no nothing oxygen thieves in your district and your worthless DM[/QUOTE]
     
  9. anonymous

    anonymous Guest

    Vyndalink sucks
     
  10. anonymous

    anonymous Guest

    Powerhouse.....No..... Hahahahaha!
     
  11. anonymous

    anonymous Guest

    The most accurate message on this board.
     
  12. anonymous

    anonymous Guest

    That’s why they called it Cluster F.......that’s what the reps and unwitting patients will be getting.....F’ed.
     
  13. anonymous

    anonymous Guest

    Fix Vyndalink
     
  14. anonymous

    anonymous Guest

    Hearing that there is a big delay in getting med to patients who’ve been approved for a while. Is this true?
     
  15. anonymous

    anonymous Guest

    so an cardiologist told me that his couple of patients that were approved have over 2k PER MONTH out of pocket for the drug. How is this sustainable!?
    Is anyone getting docs to Rx let alone get patients on therapy?
    It seems there are only a hand full of amyloidosis experts anyway... it will take a long time before it really expands to general cardiology..best they can do is screen and pass them on ... thoughts?
     
  16. anonymous

    anonymous Guest

    Vyndalink will end up sinking the product
     
  17. anonymous

    anonymous Guest

    what is vyndalink?
     
  18. anonymous

    anonymous Guest

    A form of incurable herpes